RAMSEY, N.J. (AP) — RAMSEY, N.J. (AP) — Adma Biologics Inc. (ADMA) on Wednesday reported second-quarter profit of $37.8 million.

On a per-share basis, the Ramsey, New Jersey-based company said it had profit of 16 cents.

The infectious disease drug developer posted revenue of $124.4 million in the period.

Adma Biologics expects full-year revenue in the range of $530 million to $560 million.

Adma Biologics shares have fallen 49% since the beginning of the year. In the final minutes of trading on Wednesday, shares hit $9.26, a decrease of 51% in the last 12 months.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ADMA at https://www.zacks.com/ap/ADMA